Insider · CIK 0002112997
Peter Kuan-How Lin
Files at APLM (Apollomics Inc.). First filing Aug 17, 2026, latest Aug 17, 2026.
In brief
Peter Kuan-How Lin files SEC Form 4 as CFO and director at APLM (Apollomics Inc.). Since Aug 17, 2026, Peter Kuan-How Lin has reported 1 open-market buy worth $400k and 0 open-market sells worth $0, the latest filed on Aug 17, 2026.
A track record needs three past buys with six months of prices behind them; Peter Kuan-How Lin has 0, so none is measured yet.
The newest scored trade: bought $400k of APLM on Aug 14, 2026, filed Aug 17, 2026, scored 63 (notable). In the last 12 months: 1 buy worth $400k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
APLM: Apollomics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Apollomics Inc. | $400k 26,667 shares | +120% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | APLM Apollomics Inc. | MOption exercise CLASS A ORDINARY SHARES | +10,000 | $0.00 | $0 | 58,979 | 19 d ago |
| Sep 15, 2026 | APLM Apollomics Inc. | FTax withholding CLASS A ORDINARY SHARES | -3,416 | $24.02 | $82k | 55,563 | 19 d ago |
| Sep 14, 2026 | APLM Apollomics Inc. | AGrant or award Stock option (Right to Buy)derivative | +6,000 | $0.00 | $0 | 6,000 | 19 d ago |
| Sep 15, 2026 | APLM Apollomics Inc. | MOption exercise Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 10,000 | 19 d ago |
| Sep 15, 2026 | APLM Apollomics Inc. | MOption exercise CLASS A ORDINARY SHARES | +10,000 | $0.00 | $0 | 58,979 | 26 d ago |
| Sep 15, 2026 | APLM Apollomics Inc. | FTax withholding CLASS A ORDINARY SHARES | -3,416 | $24.02 | $82k | 55,563 | 26 d ago |
| Sep 14, 2026 | APLM Apollomics Inc. | AGrant or award Stock option (Right to Buy)derivative | +6,000 | $0.00 | $0 | 6,000 | 26 d ago |
| Sep 15, 2026 | APLM Apollomics Inc. | MOption exercise Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 10,000 | 26 d ago |
| Aug 14, 2026 | APLM Apollomics Inc. | POpen-market purchase CLASS A ORDINARY SHARES | +26,667 | $15.00 | $400k | 48,979 | Aug 17, 2026 |
| Jun 15, 2026 | APLM Apollomics Inc. | MOption exercise CLASS A ORDINARY SHARES | +10,000 | $0.00 | $0 | 25,900 | Jun 17, 2026 |
| Jun 15, 2026 | APLM Apollomics Inc. | FTax withholding CLASS A ORDINARY SHARES | -3,588 | $13.85 | $50k | 22,312 | Jun 17, 2026 |
| Jun 15, 2026 | APLM Apollomics Inc. | MOption exercise Restricted Stock Unitsderivative | -10,000 | $0.00 | $0 | 10,000 | Jun 17, 2026 |
| Mar 31, 2026 | APLM Apollomics Inc. | FTax withholding CLASS A ORDINARY SHARES | -3,582 | $15.85 | $57k | 12,318 | Apr 17, 2026 |
Questions about Peter Kuan-How Lin
Answered from the filings on this page, as of the latest one.
Is Peter Kuan-How Lin buying or selling?
In the last 12 months Peter Kuan-How Lin reported 1 open-market buy worth $400k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $400k of APLM on Aug 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Peter Kuan-How Lin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Kuan-How Lin has 0.
Where does Peter Kuan-How Lin file Form 4?
Peter Kuan-How Lin has filed Form 4 at APLM (Apollomics Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.